Izuru Miyoshi

1.1k total citations · 1 hit paper
16 papers, 914 citations indexed

About

Izuru Miyoshi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Izuru Miyoshi has authored 16 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Pharmacology. Recurrent topics in Izuru Miyoshi's work include Neuroscience and Neuropharmacology Research (3 papers), Pain Management and Opioid Use (2 papers) and Alzheimer's disease research and treatments (2 papers). Izuru Miyoshi is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Pain Management and Opioid Use (2 papers) and Alzheimer's disease research and treatments (2 papers). Izuru Miyoshi collaborates with scholars based in Japan, United States and Australia. Izuru Miyoshi's co-authors include Tetsuya Kubota, Elizabeth A. Williamson, Hiroya Asou, Sylvia A. Holden, Jonathan Said, H. Phillip Koeffler, Kozo Koshizuka, Hideki Onishi, Yosuke Uchitomi and Tatsuya Morita and has published in prestigious journals such as Atherosclerosis, Journal of Pain and Symptom Management and Alzheimer s & Dementia.

In The Last Decade

Izuru Miyoshi

15 papers receiving 896 citations

Hit Papers

Ligand for peroxisome proliferator-activated receptor gam... 1998 2026 2007 2016 1998 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
    1998 534 citations Tetsuya Kubota, Kozo Koshizuka et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Izuru Miyoshi Japan 7 488 271 155 123 117 16 914
Jouni Vuorinen Finland 15 83 0.2× 119 0.4× 74 0.5× 53 0.4× 135 1.2× 28 862
Vidar M. Steen Norway 14 354 0.7× 39 0.1× 64 0.4× 20 0.2× 130 1.1× 25 969
Xiaojin Feng China 13 262 0.5× 84 0.3× 72 0.5× 31 0.3× 34 0.3× 25 875
Sarah Orr Canada 16 341 0.7× 127 0.5× 38 0.2× 94 0.8× 91 0.8× 30 1.2k
Jesús Novalbos Spain 17 162 0.3× 18 0.1× 125 0.8× 59 0.5× 91 0.8× 47 795
Maria G. Matera Italy 16 220 0.5× 49 0.2× 78 0.5× 27 0.2× 34 0.3× 28 791
Yu‐Ling Lai United States 15 135 0.3× 34 0.1× 38 0.2× 71 0.6× 64 0.5× 37 664
Laura Ribeiro Portugal 15 137 0.3× 45 0.2× 58 0.4× 47 0.4× 74 0.6× 59 707
Phuong‐Chi Pham United States 15 242 0.5× 13 0.0× 39 0.3× 88 0.7× 89 0.8× 26 1.1k

Countries citing papers authored by Izuru Miyoshi

Since Specialization
Citations

This map shows the geographic impact of Izuru Miyoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Izuru Miyoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Izuru Miyoshi more than expected).

Fields of papers citing papers by Izuru Miyoshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Izuru Miyoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Izuru Miyoshi. The network helps show where Izuru Miyoshi may publish in the future.

Co-authorship network of co-authors of Izuru Miyoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Izuru Miyoshi. A scholar is included among the top collaborators of Izuru Miyoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Izuru Miyoshi. Izuru Miyoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Hokimoto, Seiji, Hirofumi Soejima, Sunao Kojima, et al.. (2016). Distribution of Ankle-Brachial Index among Inpatients with Cardiovascular Disease: Analysis Using the Kumamoto University Hospital Medical Database. Annals of Vascular Diseases. 9(1). 22–29. 5 indexed citations
3.
Sakon, Masato, Yoshihiko Maehara, Takao Kobayashi, et al.. (2015). Economic Burden of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery. Value in Health Regional Issues. 6. 73–79. 5 indexed citations
4.
Miyoshi, Izuru, Yoko Fujimoto, Qinying Zhao, et al.. (2013). Safety and pharmacokinetics of PF-04360365 following a single-dose intravenous infusion in Japanese subjects with mild-to-moderate Alzheimerâs disease: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation study. International Journal of Clinical Pharmacology and Therapeutics. 51(12). 911–923. 20 indexed citations
5.
6.
7.
Sanjo, Makiko, Mitsunori Miyashita, Tatsuya Morita, et al.. (2008). Perceptions of Specialized Inpatient Palliative Care: A Population-Based Survey in Japan. Journal of Pain and Symptom Management. 35(3). 275–282. 18 indexed citations
8.
Morita, Tatsuya, Mitsunori Miyashita, Kei Hirai, et al.. (2006). Knowledge and Beliefs About End-of-Life Care and the Effects of Specialized Palliative Care: A Population-Based Survey in Japan. Journal of Pain and Symptom Management. 31(4). 306–316. 96 indexed citations
9.
Morita, Tatsuya, Chizuko Takigawa, Hideki Onishi, et al.. (2005). Opioid Rotation from Morphine to Fentanyl in Delirious Cancer Patients: An Open-Label Trial. Journal of Pain and Symptom Management. 30(1). 96–103. 57 indexed citations
10.
Takebayashi, Minoru, Kazue Hisaoka, Akira Nishida, et al.. (2005). Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. The International Journal of Neuropsychopharmacology. 9(5). 607–607. 108 indexed citations
11.
Miyoshi, Izuru, Ariyuki Kagaya, Shigeru Morinobu, Chie Kohchi, & Shigeto Yamawaki. (2001). Characterization of 5-HT 2A receptor desensitization and the effect of cycloheximide on it in C6 cells. Journal of Neural Transmission. 108(3). 249–260. 3 indexed citations
12.
Kagaya, Ariyuki, Hideki Katagiri, Akira Kugaya, et al.. (2001). Effect of sub-chronic treatment with duloxetine on serotonin-2A receptor function in vivo and in vitro. 16(6). 541–554. 1 indexed citations
13.
Kagaya, Ariyuki, Akiko Okada, Masatoshi Inagaki, et al.. (2000). Lithium chloride inhibits thrombin-induced intracellular calcium mobilization in C6 rat glioma cells. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 24(1). 85–95. 6 indexed citations
14.
Horiguchi, Jun, et al.. (1998). Effectiveness of valproate on delirium and/or aggressive behavior in demented patients: A practical pilot study. International Journal of Psychiatry in Clinical Practice. 2(1). 35–39. 5 indexed citations
15.
Kubota, Tetsuya, Kozo Koshizuka, Elizabeth A. Williamson, et al.. (1998). Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.. PubMed. 58(15). 3344–52. 534 indexed citations breakdown →
16.
Taguchi, Hideaki, et al.. (1982). Lethal side effects of high dose methotrexate therapy.. PubMed. 17(8). 1995–2000.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jouni Vuorinen Breakdown of academic impact, for papers by Vidar M. Steen Breakdown of academic impact, for papers by Xiaojin Feng Breakdown of academic impact, for papers by Sarah Orr Breakdown of academic impact, for papers by Jesús Novalbos Breakdown of academic impact, for papers by Maria G. Matera Breakdown of academic impact, for papers by Yu‐Ling Lai Breakdown of academic impact, for papers by Laura Ribeiro Breakdown of academic impact, for papers by Phuong‐Chi Pham
Rankless by CCL
2026